TransMedics Group, Inc.TMDXNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank23
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P23
Within normal range
vs 3Y Ago
-0.7x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-50.39%
Q3 2025-24.05%
Q2 20253308.72%
Q1 2025-114.52%
Q4 2024186.76%
Q3 2024-73.34%
Q2 2024848.70%
Q1 2024-141.37%
Q4 2023220.91%
Q3 2023-18.35%
Q2 202333.00%
Q1 2023-114.65%
Q4 202271.75%
Q3 2022-57.05%
Q2 202250.59%
Q1 2022-176.87%
Q4 202128.90%
Q3 2021-68.89%
Q2 202124.47%
Q1 2021-2.69%
Q4 2020-11.32%
Q3 202024.91%
Q2 2020-4.44%
Q1 2020-12.56%
Q4 2019-29.78%
Q3 201953.97%
Q2 2019-67.34%
Q1 2019-18.73%
Q4 2018-0.92%
Q3 201818.81%
Q2 2018-17.98%
Q1 2018-19.79%
Q4 2017-5.78%
Q3 201722.04%
Q3 20170.00%
Q2 20170.00%